Google’s AI Overviews
New AI-powered search feature produces misleading answers.
November 2014: A federal judge granted final approval of this settlement.
February 2014: A federal judge preliminarily approved a settlement to a class-action lawsuit filed against several companies regarding the marketing of Sinus Buster products. The complaint, which was originally filed in 2012, alleges that, among other things, the companies misleadingly market the products as homeopathic, effective, clinically proven to be effective, and FDA approved when, in reality, none of these things are true.
According to the settlement terms, class members with proof of purchase may receive a full refund and class members without proof of purchase may receive $5 for up to 2 Sinus Buster products. In addition, the company agreed to injunctive relief, including adding specific language and disclaimers to the packaging and referring consumers to the company’s website for more information about dilution levels. (In Re: Sinus Buster Products Consumer Litigation, Case No. 12-cv-02429, E. D. NY.).
For more information about other class-action lawsuits regarding homeopathic remedies and TINA.org’s coverage of the issue, click here.
New AI-powered search feature produces misleading answers.
Eyewear company makes marketing changes following FTC inquiry.
That is, everything except for 70 brands, among other exclusions.
For many consumers, made in the USA claims are no small fry.
The truth about sales advertised as sitewide can be ugly.